Global HIV Drugs Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14143040 | Published Date: 25-Apr-2019 | No. of pages: 136Description
TOC
Table of Contents
1 HIV Drugs Market Overview
1.1 HIV Drugs Product Overview
1.2 HIV Drugs Market Segment by Type
1.2.1 Multi-Class Combination Products
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Protease Inhibitors
1.2.5 Fusion Inhibitors
1.2.6 Entry Inhibitors - CCR5 Co-Receptor Antagonist
1.2.7 HIV Integrase Strand Transfer Inhibitors
1.3 Global HIV Drugs Market Size by Type
1.3.1 Global HIV Drugs Sales and Growth by Type
1.3.2 Global HIV Drugs Sales and Market Share by Type (2014-2019)
1.3.3 Global HIV Drugs Revenue and Market Share by Type (2014-2019)
1.3.4 Global HIV Drugs Price by Type (2014-2019)
2 Global HIV Drugs Market Competition by Company
2.1 Global HIV Drugs Sales and Market Share by Company (2014-2019)
2.2 Global HIV Drugs Revenue and Share by Company (2014-2019)
2.3 Global HIV Drugs Price by Company (2014-2019)
2.4 Global Top Players HIV Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 HIV Drugs Market Competitive Situation and Trends
2.5.1 HIV Drugs Market Concentration Rate
2.5.2 Global HIV Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 HIV Drugs Company Profiles and Sales Data
3.1 Bristol-Myers Squibb
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 HIV Drugs Product Category, Application and Specification
3.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Gilead Sciences
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 HIV Drugs Product Category, Application and Specification
3.2.3 Gilead Sciences HIV Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 GlaxoSmithKline
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 HIV Drugs Product Category, Application and Specification
3.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Johnson & Johnson
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 HIV Drugs Product Category, Application and Specification
3.4.3 Johnson & Johnson HIV Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Merck
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 HIV Drugs Product Category, Application and Specification
3.5.3 Merck HIV Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
4 HIV Drugs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global HIV Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global HIV Drugs Sales and Revenue by Regions
4.2.1 Global HIV Drugs Sales and Market Share by Regions (2014-2019)
4.2.2 Global HIV Drugs Revenue and Market Share by Regions (2014-2019)
4.2.3 Global HIV Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America HIV Drugs Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe HIV Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific HIV Drugs Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America HIV Drugs Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa HIV Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 HIV Drugs Application/End Users
5.1 HIV Drugs Segment by Application
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.1.4 Others
5.2 Global HIV Drugs Product Segment by Application
5.2.1 Global HIV Drugs Sales by Application
5.2.2 Global HIV Drugs Sales and Market Share by Application (2014-2019)
6 Global HIV Drugs Market Forecast
6.1 Global HIV Drugs Sales, Revenue Forecast (2019-2025)
6.1.1 Global HIV Drugs Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global HIV Drugs Revenue and Growth Rate Forecast (2019-2025)
6.2 Global HIV Drugs Forecast by Regions
6.2.1 North America HIV Drugs Sales and Revenue Forecast (2019-2025)
6.2.2 Europe HIV Drugs Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific HIV Drugs Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America HIV Drugs Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa HIV Drugs Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 HIV Drugs Forecast by Type
6.3.1 Global HIV Drugs Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Multi-Class Combination Products Gowth Forecast
6.3.3 Nucleoside Reverse Transcriptase Inhibitors Gowth Forecast
6.4 HIV Drugs Forecast by Application
6.4.1 Global HIV Drugs Sales Forecast by Application (2019-2025)
6.4.2 Global HIV Drugs Forecast in Hospital Pharmacies
6.4.3 Global HIV Drugs Forecast in Retail Pharmacies
7 HIV Drugs Upstream Raw Materials
7.1 HIV Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 HIV Drugs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure HIV Drugs Product Picture
Figure Global HIV Drugs Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global HIV Drugs Sales (K MT) Status and Outlook (2014-2025)
Figure Product Picture of Multi-Class Combination Products
Table Major Players of Multi-Class Combination Products
Figure Global Multi-Class Combination Products Sales (K MT) and Growth Rate (%)(2014-2018)
Figure Product Picture of Nucleoside Reverse Transcriptase Inhibitors
Table Major Players of Nucleoside Reverse Transcriptase Inhibitors
Figure Global Nucleoside Reverse Transcriptase Inhibitors Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors
Table Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of Protease Inhibitors
Table Major Players of Protease Inhibitors
Figure Global Protease Inhibitors Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of Fusion Inhibitors
Table Major Players of Fusion Inhibitors
Figure Global Fusion Inhibitors Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Table Major Players of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Figure Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of HIV Integrase Strand Transfer Inhibitors
Table Major Players of HIV Integrase Strand Transfer Inhibitors
Figure Global HIV Integrase Strand Transfer Inhibitors Sales (K MT) and Growth Rate (%)(2014-2019)
Table Global HIV Drugs Sales (K MT) and Growth Rate (%) Comparison by Type
Table Global HIV Drugs Sales (K MT) by Type (2014-2019)
Table Global HIV Drugs Sales Share (%) by Type (2014-2019)
Figure Global HIV Drugs Sales Market Share (%) by Type (2014-2019)
Figure Global HIV Drugs Sales Market Share (%) by Type in 2018
Table Global HIV Drugs Revenue (Million USD) by Type (2014-2019)
Table Global HIV Drugs Revenue Share (%) by Type (2014-2019)
Figure Global HIV Drugs Revenue Share (%) by Type (2014-2019)
Figure 2018 Global HIV Drugs Revenue Market Share (%) by Type
Table Global HIV Drugs Price (USD/MT) by Type (2014-2019)
Table Global HIV Drugs Sales (K MT) by Company (2014-2019)
Table Global HIV Drugs Sales Share (%) by Company (2014-2019)
Figure Global HIV Drugs Sales Share (%) by Company in 2018
Table Global HIV Drugs Revenue (Million USD) by Company (2014-2019)
Table Global HIV Drugs Revenue Share (%) by Company (2014-2019)
Figure Global HIV Drugs Revenue Share (%) by Company in 2018
Table Global Market HIV Drugs Average Price (USD/MT) by Company (2014-2019)
Table Global HIV Drugs Top Players Manufacturing Base Distribution and Sales Area
Table Global HIV Drugs Top Players Product Category
Figure Global HIV Drugs Market Share (%) of Top 5 Players
Figure Global HIV Drugs Market Share (%) of Top 10 Players
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb HIV Drugs Product Category, Application and Specification
Table Bristol-Myers Squibb HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb HIV Drugs Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb HIV Drugs Sales Global Market Share (%)(2014-2019)
Table Gilead Sciences Basic Information List
Figure Gilead Sciences HIV Drugs Product Category, Application and Specification
Table Gilead Sciences HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Gilead Sciences HIV Drugs Sales Growth Rate (2014-2019)
Figure Gilead Sciences HIV Drugs Sales Global Market Share (%)(2014-2019)
Table GlaxoSmithKline Basic Information List
Figure GlaxoSmithKline HIV Drugs Product Category, Application and Specification
Table GlaxoSmithKline HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure GlaxoSmithKline HIV Drugs Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline HIV Drugs Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson HIV Drugs Product Category, Application and Specification
Table Johnson & Johnson HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson HIV Drugs Sales Growth Rate (2014-2019)
Figure Johnson & Johnson HIV Drugs Sales Global Market Share (%)(2014-2019)
Table Merck Basic Information List
Figure Merck HIV Drugs Product Category, Application and Specification
Table Merck HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Merck HIV Drugs Sales Growth Rate (2014-2019)
Figure Merck HIV Drugs Sales Global Market Share (%)(2014-2019)
Table Global HIV Drugs Market Size Comparison by Regions (2014-2025)
Figure North America HIV Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific HIV Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe HIV Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America HIV Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa HIV Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global HIV Drugs Sales (K MT) by Regions (2014-2019)
Table Global HIV Drugs Sales Market Share (%) by Regions (2014-2019)
Figure Global HIV Drugs Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global HIV Drugs Sales Market Share (%) by Regions
Table Global HIV Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global HIV Drugs Revenue Market Share (%) by Regions (2014-2019)
Figure Global HIV Drugs Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global HIV Drugs Revenue Market Share (%) by Regions
Table Global HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure North America HIV Drugs Sales Growth Rate
Table North America HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure United States HIV Drugs Sales (K MT)(2014-2019)
Figure United States HIV Drugs Revenue (Million USD)(2014-2019)
Figure Canada HIV Drugs Sales (K MT)(2014-2019)
Figure Canada HIV Drugs Revenue (Million USD)(2014-2019)
Figure Mexico HIV Drugs Sales (K MT)(2014-2019)
Figure Mexico HIV Drugs Revenue (Million USD)(2014-2019)
Figure Europe HIV Drugs Sales Growth Rate
Table Europe HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Germany HIV Drugs Sales (K MT)(2014-2019)
Figure Germany HIV Drugs Revenue (Million USD) (2014-2019)
Figure UK HIV Drugs Sales (K MT)(2014-2019)
Figure UK HIV Drugs Revenue (Million USD)(2014-2019)
Figure France HIV Drugs Sales (K MT)(2014-2019)
Figure France HIV Drugs Revenue (Million USD)(2014-2019)
Figure Italy HIV Drugs Sales (K MT)(2014-2019)
Figure Italy HIV Drugs Revenue (Million USD)(2014-2019)
Figure Russia HIV Drugs Sales (K MT)(2014-2019)
Figure Russia HIV Drugs Revenue (Million USD)(2014-2019)
Figure Turkey HIV Drugs Sales (K MT)(2014-2019)
Figure Turkey HIV Drugs Revenue (Million USD)(2014-2019)
Figure Asia-Pacific HIV Drugs Sales Growth Rate
Table Asia-Pacific HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure China HIV Drugs Sales (K MT)(2014-2019)
Figure China HIV Drugs Revenue (Million USD)(2014-2019)
Figure Japan HIV Drugs Sales (K MT)(2014-2019)
Figure Japan HIV Drugs Revenue (Million USD)(2014-2019)
Figure Korea HIV Drugs Sales (K MT)(2014-2019)
Figure Korea HIV Drugs Revenue (Million USD)(2014-2019)
Figure Southeast Asia HIV Drugs Sales (K MT)(2014-2019)
Figure Southeast Asia HIV Drugs Revenue (Million USD)(2014-2019)
Figure Indonesia HIV Drugs Sales (K MT)(2014-2019)
Figure Indonesia HIV Drugs Revenue (Million USD)(2014-2019)
Figure Thailand HIV Drugs Sales (K MT)(2014-2019)
Figure Thailand HIV Drugs Revenue (Million USD)(2014-2019)
Figure Malaysia HIV Drugs Sales (K MT)(2014-2019)
Figure Malaysia HIV Drugs Revenue (Million USD)(2014-2019)
Figure Philippines HIV Drugs Sales (K MT)(2014-2019)
Figure Philippines HIV Drugs Revenue (Million USD)(2014-2019)
Figure Vietnam HIV Drugs Sales (K MT)(2014-2019)
Figure Vietnam HIV Drugs Revenue (Million USD)(2014-2019)
Figure India HIV Drugs Sales (K MT)(2014-2019)
Figure India HIV Drugs Revenue (Million USD)(2014-2019)
Figure Australia HIV Drugs Sales (K MT)(2014-2019)
Figure Australia HIV Drugs Revenue (Million USD)(2014-2019)
Figure South America HIV Drugs Sales Growth Rate
Table South America HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Brazil HIV Drugs Sales (K MT)(2014-2019)
Figure Brazil HIV Drugs Revenue (Million USD)(2014-2019)
Figure Middle East and Africa HIV Drugs Sales Growth Rate
Table Middle East and Africa HIV Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure North Africa HIV Drugs Sales (K MT)(2014-2019)
Figure North Africa HIV Drugs Revenue (Million USD)(2014-2019)
Figure GCC Countries HIV Drugs Sales (K MT)(2014-2019)
Figure GCC Countries HIV Drugs Revenue (Million USD)(2014-2019)
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacies Examples
Figure Others Examples
Table Global HIV Drugs Sales (K MT) Comparison by Application (2014-2025)
Table Global HIV Drugs Sales (K MT) by Application (2014-2019)
Table Global HIV Drugs Sales Share (%) by Application (2014-2019)
Figure Global HIV Drugs Sales Market Share (%) by Application (2014-2019)
Figure Global HIV Drugs Sales Market Share (%) by Application in 2018
Figure Global HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Global HIV Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global HIV Drugs Sales (K MT) Forecast by Regions (2019-2025)
Figure Global HIV Drugs Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure North America HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Europe HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure China HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Japan HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Korea HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure India HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Australia HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure South America HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries HIV Drugs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries HIV Drugs Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global HIV Drugs Sales (Million USD) Forecast by Type (2019-2025)
Figure Global HIV Drugs Sales Market Share (%) Forecast by Type (2019-2025)
Table Global HIV Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global HIV Drugs Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Multi-Class Combination Products Sales Growth Forecast
Figure Nucleoside Reverse Transcriptase Inhibitors Sales Growth Forecast
Table Global HIV Drugs Sales (K MT) Forecast by Application (2019-2025)
Figure Global HIV Drugs Sales Forecast by Application (2019-2025)
Figure Global HIV Drugs Sales (K MT) Forecast in Hospital Pharmacies
Figure Global HIV Drugs Sales (K MT) Forecast in Retail Pharmacies
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure HIV Drugs Manufacturing Cost Structure
Figure HIV Drugs Industrial Chain Analysis
Table Distributors List
Table HIV Drugs Downstream Customers
Companies
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
- PRICE
-
$3350$6700$5025Buy Now